IBEC success in Human Brain Project funding call Blog Post

A study involving IBEC group leader and ICREA research professor Pau Gorostiza has been chosen for funding under a Call for Expressions of Interest (CEol) on Systems and Cognitive Neuroscience by the Human Brain Project (HBP) FET Flagship. Thanks to their success in this Call, the project partners – including IBEC – will be integrated in the broader HBP Consortium. 

 

IBEC researcher Samuel Sanchez at the ‘Innovators Under 35 Europe’ summit Blog Post

Samuel Sánchez, researcher at the Institute for Bioengineering of Catalonia (IBEC) at PCB, was among the experts invited to participate at the European summit of the winners of the MIT Technology Review’s Innovators Under 35 Europe award, which was held last week in Brussels. The research conducted by Samuel Sánchez is pioneer in the field of micro- and nanomotors, small machines such as bacteria that can target specific body cells for applications such as localized drug delivery.

 

Spain and France join the European Consortium Elixir for managing and analysing biological data Blog Post

At their meeting today in Hinxton (UK), the Board unanimously accepted Spain and France as full members of Elixir, the largest infrastructure of life science data in Europe. The National Bioinformatics Institute (INB), which acts as the Spanish scientific node, will coordinate the Spanish scientific partner institutions. These comprise top-level institutions such as CNAG-CRG and IRB Barcelona, located at PCB. The National Institute of Health Carlos III (ISCII) will coordinate the Spanish scientific partner institutions.

 

Artax is granted 10 million dollars to foster clinical trials with an innovative drug in patients who suffer from autoimmune disorders Blog Post

The start-up Artax Biopharma –focusing on the development of first-in-class drugs to treat autoimmune diseases- has closed a Series B series investment funding round totaling $10 Million to boost clinical trials of its most advanced compound, drug AX- 024. This biotech- based in Cambridge (Massachusetts) and founded by Damià Tormo, a scientist and entrepreneur from Valencia– leads a team in Spain that manages a large part of the project in Europe from its offices located in Valencia and at Barcelona Science Park (PCB). 

 

The 20 Severo Ochoa Centers of Excellence organise 100xCIENCIA Forum Blog Post

The 20 Spanish research centers accredited with the Severo Ochoa Excellence distinction– two of which are the Institute for Bioengineering of Catalonia (IBEC) and the Institute for Research in Biomedicine (IRB Barcelona), based at PCB–  met for the first time and for three days, to analyze the current situation of Spanish science and its key actors under the framework of ‘100XCIENCIA Communicating frontier science. The event, which was held from 7 to 9 October in Santa Cruz de la Palma, was closed a clear message: Science has to be conveyed to society for continued growth.

 

Researchers at IBEC and UAB have found a mycobacterium that is more effective in treating superficial bladder cancer Blog Post

Researchers from Institute for Bioengineering of Catalonia (IBEC), at Barcelona Science Park (PCB), with the Mycobacteria Research Group of the Department of Genetics and Microbiology, at Universitat Autònoma de Barcelona (UAB), have found a mycobacterium that is more effective in treating superficial bladder cancer and does not cause infections, unlike those used up to now. 

 

Secretary of State visits IBEC at the Barcelona Science Park Blog Post

This morning, Secretary of State for Research, Development and Innovation, Carmen Vela, visited the Institute for Bioengineering of Catalonia (IBEC) at PCB, after taking part in the opening ceremony of the conference ‘Future Tools for Biomedical Research. In Vitro, in Silico and in Vivo Disease Modeling‘, organized by B·Debate, International Center for Scientific Debate – an initiative of Biocat and “la Caixa” – jointly with IBEC. 

 

IBUB has participated in a international study to identify a novel gene implicated in osteoporosis Blog Post

Un uncommon variant of the gene EN1 contributes to bone mineral density and osteoporotic fractures, according to a study recently published in the journal Nature. Daniel Grinberg, expert in the Department of Genetics of the University of Barcelona (UB) and member of the Institute of Biomedicine of the UB (IBUB) at Barcelona Science Park (PCB) has participated in the study, wich is part of the international project Genetic Factors for Osteoporosis Consortium (GEFOS), funded by the European Union.